Advanced Delivery Technologies Expand Opportunity Beyond therapeutic innovation itself, SureNano Science is also pursuing differentiated drug-delivery technologies designed to improve patient accessibility and adherence
For many people living in the U.S., the high retail costs of semaglutide (Ozempic and Wegovy) can reach $1,000+ per month without insurance coverage
One year after stopping all treatment, 63% of participants who received combination liraglutide plus supervised exercise were able to maintain 5% weight loss and 45% maintained 10% weight loss
Oral options are now becoming more important, including oral semaglutide formulations and orforglipron, marketed as Foundayo
Microdosing GLP-1 for autoimmune conditions is an emerging area of interest, with some practitioners maintaining patients on very low doses primarily for anti-inflammatory benefits rather than weight management
we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.